A new Schiff base, [H(4)pydmedpt](2+)·2Cl(-), derived from one of the forms of vitamin B(6) has been synthesized by condensation of pyridoxal hydrochloride with N,N-bis[3-aminopropyl]-methylamine (medpt) and characterized by analytical and spectroscopic methods. The molecular structure is calculated by density functional theory (DFT) procedures, and the donor properties of each individual donor atom are evaluated by calculation of the Fukui function. One pot reaction of pyridoxal and medpt with vanadyl acetylacetonate yields the brown complex [V(IV)O(H(2)pydmedpt)](2+)·2Cl(-)1, which upon recrystallization from water crystallizes as [V(IV)O(pydmedpt)]·5H(2)O 2. The compounds are characterized by analytical and spectroscopic methods, 2 being also characterized by single crystal X-ray diffraction. It displays a slightly distorted octahedral geometry around the vanadium atom involving the coordination of N(amine), two N(imine), and O(phenolato) donors of the ligand. One of the phenolato oxygen donors is positioned trans to the terminal O-oxido atom with relatively short V-O(phenolate) {2.041(3) Å} and long V-O(oxido) {1.625(4) Å} bond distances when compared to other known compounds. The two different pK(a) values (6.0 and 7.9) obtained for 1 are due to protonation of the pyridine ring nitrogen atoms having different basic characters, this being also substantiated by theoretical calculation of the proton affinity of the O- and N- atoms of the molecule. The spin Hamiltonian parameters are obtained from the electron paramagnetic resonance (EPR) spectra, but the A(z) value (ca. 155 × 10(-4) cm(-1)) is lower than expected by applying the additivity rule for the present set of equatorial donor atoms (ca. 162-163 × 10(-4) cm(-1)), this being attributed to the strong trans V-O(phenolate) bond. The UV-vis transitions and EPR spectral parameters are calculated by DFT procedures, and both the calculated electronic transitions and the hyperfine coupling constants agree well with those experimentally observed. The inhibitory effect of 1 on FFA release and % glucose uptake determined with isolated rat adipocyte cells gave IC(50) and EC(50) values lower than for V(IV)OSO(4) and of the same order of magnitude of other reported insulin enhancing vanadium compounds.

BackgroundSome reports indicate financial concerns as a factor affecting ED patients leaving the acute care setting against medical advice (AMA). In India, no person is supposed to be denied urgent care because of inability to pay. Since a large proportion of the Indian health care system is financed by out-of-pocket expenses, we investigate the role of financial constraints for ED patients at a private hospital in India in leaving AMA.MethodsA prospective ED-based cross-sectional survey of patients leaving AMA was conducted at a private hospital in India from 1 October 2010 to 31 December 2010. Descriptive statistics and the chi-square test were used to identify associations between financial factors and the decision to leave the hospital AMA.ResultsOverall, 55 (3.84%) ED patients left AMA, of which 46 (84%) reported leaving because of financial restrictions. Thirty-nine (71%) respondents indicated the medical bill would represent more that 25% of their annual income. Females (19/19) were more likely to leave AMA for financial reasons compared to males (27/36, p = 0.017). Among females who signed out AMA, the decision was never made by the female herself.ConclusionThe number of people leaving the ED AMA in a private Indian hospital is relatively high, with most leaving for financial reasons. In most cases, women did not decide to leave the ED AMA for themselves, whereas males did. This survey suggests that steps are needed to ensure that the inability to pay does not prevent emergent care from being provided.

This paper describes the activity of a Schiff base ligand, derived from pyridoxal, as a promising fluorescence probe for biologically important Zn(II) ion sensing. This is the first report of a vitamin based ligand as a fluorescent probe for sensing Zn(II) ions. The Schiff base H 2 pydmedpt, derived from the condensation of pyridoxal ( pyd) and N,N-bis[3-aminopropyl]methylamine (medpt), exhibits around a 325-fold increase in fluorescence quantum yield due to zinc triggered fluorescence switching. The response is specific for Zn(II) ions, and remains unaffected by the presence of alkali and alkaline earth metals but is suppressed to varying degrees by transition metal ions. The corresponding Zn(II)-complex, [Zn( pydmedpt], is isolated. The DFT optimized structure of the complex is compatible with elemental analysis, mass spectrometry, FT-IR, electronic and NMR spectra. The isolated complex, having pK a values of ∼5.3 and ∼5, is a moderate intercalator for DNA with an apparent binding constant of 2.3 × 10 6 M −1 . The complex also shows insulin-enhancing activity at par with other reported complexes, with an IC 50 value of 0.65 with respect to ZnSO 4 . † Electronic supplementary information (ESI) available. See

Three new complexes of Cu(II) and Ni(II), [Cu(II)(H(2)pydmedpt)](2+)·2Cl(-) (1), [Ni(II)(H(2)pydmedpt)](2+)·2Cl(-) (2) and [Ni(II)(pydmedpt)(OH)](-)·K(+) (3) of the Schiff base ligand [H(2)pydmedpt](2+)·2Cl(-) were synthesized by the in situ reaction of pyridoxal (pyd), a vitamer of vitamin B(6), N,N-bis[3-aminopropyl]methylamine (medpt) and copper(II) acetate or nickel(II) acetate, respectively. The molecular structures of 1 and 2 were determined by single crystal X-ray diffraction studies. The structure of 3 in the solid state was inferred by elemental analysis, diffuse reflectance spectrum, variable temperature magnetic moment studies and DFT calculations. The binding of the Schiff base ligand to the metal centers involves two phenolato oxygens, two imine nitrogens and one amine nitrogen. The coordination geometry around Cu in 1 is distorted square pyramidal and that around the Ni atom in 2 is intermediate between square-pyramidal and trigonal-bipyramidal. In the crystals the compounds form supramolecular one dimensional chain structures stabilized by hydrogen bonding and π-π stacking interactions. Variable temperature magnetic moment data of 2 indicate the presence of a momomeric high spin Ni(II) centre in the complex. The solid state diffuse reflectance spectrum, conductance and elemental analysis suggest that 3 is a Ni(II) complex with a tetragonally distorted octahedral field, the sixth position being occupied by the oxygen atom of a hydroxyl group. The variable temperature magnetic moment of 3 indicates the presence of a ferromagnetic dinuclear species (29.2%) along with the major monomeric species, the intra-dimer exchange term J value being 14.3 cm(-1). The competitive binding of 1 and 2 with DNA was studied in the concentration range 40 to 400 μM, the apparent binding constants being K = 2.9 × 10(3) and 6.7 × 10(3) M(-1), respectively. Human Serum Albumin (HSA) binding studies were carried out at concentrations of 800-1000 μM and 400-500 μM for the complexes and HSA, respectively, in PBS buffer at pH 7.4. Complex 1 binds to HSA, while no binding is observed in case of 2, instead, the complex hydrolyses under the experimental conditions used and the resulting Ni(2+) ions bind with HSA.

No abstract